Where does Genofocus Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Genofocus Co., Ltd. ranks #47,015 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Genofocus Co., Ltd. hold?

Genofocus Co., Ltd. holds 5 US utility patents granted between 2018 and 2021, spanning 9 technology areas.

What is Genofocus Co., Ltd.'s Innovation Score?

Genofocus Co., Ltd. has an Innovation Score of 20.4 out of 100 (7th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Genofocus Co., Ltd. focus on?

Genofocus Co., Ltd.'s top technology area is C12Y (Enzymes) with 4 patents. Grants appear in 9 CPC subclasses total.

Is Genofocus Co., Ltd.'s patent grant rate increasing or decreasing?

Genofocus Co., Ltd.'s recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Genofocus Co., Ltd.'s patents?

Genofocus Co., Ltd.'s patents average 6.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Genofocus Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Genofocus Co., Ltd.

USPTO PatentsView assignee record - 5 granted patents across 9 technology areas, recorded in grant years 2018–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Y (Enzymes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Genofocus ranks #47,015 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 9 technology areas.

#47,015
of 49,997 US assignees by volume: 7th percentile
by Innovation Score (20.4/100): 6.0
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R47015 · Foreign Corporation #47,015 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #47,015/49,997
PHOTO-FINISH General Research…
CPC-NARROW C12Y · 9 areas
INNOV-THIN 20.4/100
CLAIMS-SPARSE 6.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: General Research Institute FOR Nonferrous Metals (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Genofocus · this assignee

20
3D Lighting… · lowest

7

What this shows Genofocus's Innovation Score is 20.4/100 (7th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Genofocus's grants concentrate

Genofocus Co., Ltd. is a focused PatentsView assignee: 9 CPC subclasses with 80% of grants classified under C12Y (Enzymes). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2018. By volume, Genofocus sits between General Research Institute FOR Nonferrous Metals and Gensun Institute OF Biomedicine Co., Ltd..

General Research…

5
Genesis Industries

5
Genesis LAB

5
Genial Light

5
Genoplante-valor

5
Genovie AB

5
Gensight Biologics

5
Gensun Institute…

5
Genofocus ◀

5

What this shows Genofocus holds 5 patents at rank #46,987, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Genofocus

By rank, the assignees closest to #46,987 in granted patent volume.

Leaders in C12Y (Enzymes)

Other assignees with the most granted patents in Genofocus's primary technology class.

Genofocus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

20 7th percentile higher than 7% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Genofocus Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	20.0%
2019	1	20.0%
2020	2	40.0%
2021	1	20.0%

Which technologies does Genofocus Co., Ltd. patent most?

C12Y - Enzymes 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 1

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 1

A23K - Fodder 1

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

Top 9 of 9 technology areas

Where it ranks

Overall rank by patents

#47,015

of 49,997 tracked assignees

Innovation Score

20.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Genofocus Co., Ltd.'s patent record in context - here's where to go next.

Genofocus Co., Ltd.'s lead technology class is C12Y (Enzymes), 80% of its portfolio - see every assignee active in that class. Explore C12Y
Ranked #47,015 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Genofocus Co., Ltd. against General Research Institute FOR Nonferrous Metals, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 20.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.